##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##PIPELINE=megSAP 0.1-742-ged8ba02
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD_sub	ESP_sub	gnomAD	phyloP	PolyPhen	Sift	OMIM	fathmm-MKL	CADD	REVEL	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	gene_info
chr1	120539331	120539331	C	T	het	low_MQM	QUAL=30961;DP=1886;AF=0.52;MQM=49	NOTCH2	intron_variant	NOTCH2:NM_024408.3:intron_variant:MODIFIER:exon4/33:c.751+289G>A:,NOTCH2:NM_001200001.1:intron_variant:MODIFIER:exon4/21:c.751+289G>A:		rs2124109	0	0.44	0.44	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM248829	0	867				SAMD11 (inh=n/a pLI=0.00)
chr1	120611496	120611496	C	A	het	low_MQM	QUAL=393;DP=41;AF=0.49;MQM=47	NOTCH2	intron_variant	NOTCH2:NM_024408.3:intron_variant:MODIFIER:exon1/33:c.73+452G>T:,NOTCH2:NM_001200001.1:intron_variant:MODIFIER:exon1/21:c.73+452G>T:		rs138685616	0	0.074	0.074	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];							12	174				SAMD11 (inh=n/a pLI=0.00)
chr1	120611960	120611960	C	T	het	low_MQM	QUAL=9250;DP=1920;AF=0.21;MQM=47	NOTCH2	missense_variant	NOTCH2:NM_024408.3:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr,NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.61G>A:p.Ala21Thr		rs2603926	0	0.259	0.259	0	0.4330	T	T	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM1600651	0	643				SAMD11 (inh=n/a pLI=0.00)
chr1	120611964	120611964	G	C	het		QUAL=22127;DP=1927;AF=0.38;MQM=58	NOTCH2	missense_variant	NOTCH2:NM_024408.3:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0	0.406	0.406	0	0.7660	T,T	.,T	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM132738	5	1181				SAMD11 (inh=n/a pLI=0.00), NOC2L (inh=n/a pLI=0.00)
chr1	120612003	120612004	GG	-	het	low_MQM;anno_high_impact	QUAL=8237;DP=2016;AF=0.19;MQM=47	NOTCH2	frameshift_variant	NOTCH2:NM_024408.3:frameshift_variant:HIGH:exon1/34:c.17_18delCC:p.Pro6fs,NOTCH2:NM_001200001.1:frameshift_variant:HIGH:exon1/22:c.17_18delCC:p.Pro6fs		rs372504208	0	0.343	0.343	0				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM132830	0	650	3	[3] old entry - no details available		SAMD11 (inh=n/a pLI=0.00), NOC2L (inh=n/a pLI=0.00)
chr1	120612006	120612006	G	A	het		QUAL=24336;DP=2004;AF=0.39;MQM=58	NOTCH2	synonymous_variant	NOTCH2:NM_024408.3:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous_variant:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.394	0.422	0.422	0	1.0740			600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				RCV000173523.1 [uncertain significance]; 		COSM1320072	1	1178				NOC2L (inh=n/a pLI=0.00)
chr1	120612034	120612034	T	G	het	low_MQM	QUAL=8088;DP=1994;AF=0.20;MQM=47	NOTCH2	5_prime_UTR_variant	NOTCH2:NM_024408.3:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C:,NOTCH2:NM_001200001.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-14A>C:	(CGC)n	rs201668322	0	0.124	0.124	0											0	363				NOC2L (inh=n/a pLI=0.00)
chr2	48030692	48030692	T	A	het	low_DP	QUAL=288;DP=17;AF=0.65;MQM=60	MSH6,FBXO11	synonymous_variant,downstream_gene_variant	MSH6:NM_000179.2:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:NM_001281492.1:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:NM_001281493.1:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800Thr,MSH6:NM_001281494.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800Thr,FBXO11:NM_001190274.1:downstream_gene_variant:MODIFIER::c.*2857A>T:,FBXO11:NM_025133.4:downstream_gene_variant:MODIFIER::c.*2646A>T:		rs2020910	0.0493	0.02	0.02	0.0016				600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];				RCV000030267.3 [benign]; RCV000078313.4 [benign]; RCV000162391.1 [benign]; 			0	9				NOC2L (inh=n/a pLI=0.00)
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079,0.0123	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	12			n/a (1xTP, 0xFP)	NOC2L (inh=n/a pLI=0.00)
chr2	220422686	220422686	C	T	het	pred_pathogenic_2	QUAL=700;DP=62;AF=0.44;MQM=60	OBSL1	missense_variant,downstream_gene_variant	OBSL1:NM_015311.2:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173431.1:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173408.1:downstream_gene_variant:MODIFIER::c.*3392G>A:		rs72957510	0.007	0.0234,0.0055	0.0234,0.0055	0.0055	0.5010	T	T,D,T,T	610991 [OBSL1 (confirmed) 3-M syndrome 2];				RCV000174131.1 [benign]; 			2	26				KLHL17 (inh=n/a pLI=0.00)
chr3	10085536	10085536	A	G	het		QUAL=3006;DP=292;AF=0.43;MQM=60	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0	0.122	0.122	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM3759562, COSM3759563	0	474				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10088404	10088404	C	T	het	low_MQM	QUAL=512;DP=113;AF=0.20;MQM=17	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon15/43:c.1275C>T:p.Tyr425Tyr,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon15/44:c.1275C>T:p.Tyr425Tyr			0	0.054	0.054	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM1417229, COSM1417230	0	956				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10088410	10088412	AAG	-	het	low_MQM	QUAL=512;DP=113;AF=0.20;MQM=17	FANCD2	splice_region_variant&intron_variant	FANCD2:NM_033084.3:splice_region_variant&intron_variant:LOW:exon15/42:c.1278+3_1278+5delAAG:,FANCD2:NM_001018115.1:splice_region_variant&intron_variant:LOW:exon15/43:c.1278+3_1278+5delAAG:		rs375350046	0	0.036	0.036	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							0	917				PERM1 (inh=n/a pLI=n/a)
chr3	10089723	10089723	G	A	het	low_MQM	QUAL=817;DP=147;AF=0.22;MQM=35	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0	0.446	0.446	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM4157098, COSM4157099	0	1215				PERM1 (inh=n/a pLI=n/a)
chr3	10089738	10089738	A	G	het	low_MQM	QUAL=571;DP=119;AF=0.22;MQM=29	FANCD2	splice_region_variant&intron_variant	FANCD2:NM_033084.3:splice_region_variant&intron_variant:LOW:exon16/42:c.1413+3A>G:,FANCD2:NM_001018115.1:splice_region_variant&intron_variant:LOW:exon16/43:c.1413+3A>G:		rs62245508	0	0.437	0.437	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							0	1211	1	[1] old entry - no details available	n/a (1xTP, 0xFP)	PERM1 (inh=n/a pLI=n/a)
chr3	10091153	10091153	C	T	het	low_MQM	QUAL=126;DP=63;AF=0.17;MQM=40	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503Asn		rs35652360	0	0.014	0.014	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];							10	247				PERM1 (inh=n/a pLI=n/a)
chr3	10106532	10106532	C	T	het		QUAL=1466;DP=74;AF=0.64;MQM=60	FANCD2	missense_variant	FANCD2:NM_033084.3:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0	0.155	0.155	0	-0.1810	T	T,T,T,T	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				RCV000120989.1 [not provided]; 			32	430				PERM1 (inh=n/a pLI=n/a)
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145327.1 [uncertain significance]; 			0	17				ISG15 (inh=AR pLI=0.01)
chr5	79950781	79950781	A	G	het		QUAL=526;DP=38;AF=0.47;MQM=60	MSH3,DHFR,MTRNR2L2	missense_variant&splice_region_variant,5_prime_UTR_variant,upstream_gene,non_coding_exon_variant	MSH3:NM_002439.4:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:NM_000791.3:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C:,DHFR:NM_001290354.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-579T>C:,DHFR:NM_001290357.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-473T>C:,MTRNR2L2:NM_001190470.1:upstream_gene:MODIFIER::c.-950T>C:,DHFR:NR_110936.1:non_coding_exon_variant:MODIFIER:exon1/4:n.20T>C:		rs1650697	0.7686	0.854	0.854	0	-0.4930	T	T,T	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic];					CM003459 [CLASS=DP MUT=REF PHEN="Colon cancer association with" GENE=MSH3]; 	COSM4160035	797	497				AGRN (inh=AR pLI=0.17)
chr5	131925483	131925483	G	C	het		QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense_variant	RAD50:NM_005732.3:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0.0001	0	6.3310	T	T,T,T	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];							0	0				AGRN (inh=AR pLI=0.17)
chr7	6037057	6037057	-	A	het		QUAL=285;DP=23;AF=0.48;MQM=60	PMS2	splice_region_variant&intron_variant	PMS2:NM_000535.5:splice_region_variant&intron_variant:LOW:exon6/14:c.706-4_706-3insT:,PMS2:NR_003085.2:splice_region_variant&intron_variant:LOW:exon6/14:n.788-4_788-3insT:		rs570998668	0	0	0	0				600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				RCV000179768.1 [benign]; 		COSM1735804	0	145				AGRN (inh=AR pLI=0.17)
chr7	142460313	142460313	T	C	hom		QUAL=4873;DP=163;AF=0.99;MQM=60	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.369	0.369	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];					CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	157	933				AGRN (inh=AR pLI=0.17)
chr7	142460865	142460865	T	C	hom		QUAL=10084;DP=347;AF=1.00;MQM=59	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.504	0.504	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];							443	685				AGRN (inh=AR pLI=0.17)
chr9	21971137	21971137	T	G	het	pred_pathogenic_4	QUAL=404;DP=50;AF=0.46;MQM=60	CDKN2A,C9orf53	missense_variant,synonymous_variant,3_prime_UTR_variant,downstream_gene_variant	CDKN2A:NM_001195132.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala,CDKN2A:NM_000077.4:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala,CDKN2A:NM_058195.3:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88Arg,CDKN2A:NM_058197.4:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C:,C9orf53:NR_024274.1:downstream_gene_variant:MODIFIER::n.*616T>G:		rs200429615	0	0.0011	0.0011	0	5.3730	D	D,D	156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma]:600160 [CDKN2A (confirmed) Melanoma,cutaneous malignant,2|Melanoma and neural system tumor syndrome|Pancreatic cancer/melanoma syndrome|Orolaryngeal cancer,multiple,];						COSM4163711, COSM4163712, COSM4163709, COSM4163710	7	327	1	[1] old entry - no details available		PUSL1 (inh=n/a pLI=0.00)
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region_variant&intron_variant,non_coding_exon_variant	PTCH1:NM_000264.3:splice_region_variant&intron_variant:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon_variant:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018				601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];							0	3				INTS11 (inh=n/a pLI=0.00)
chr11	94212930	94212930	-	A	het		QUAL=410;DP=514;AF=0.11;MQM=60	MRE11A	splice_region_variant&intron_variant	MRE11A:NM_005591.3:splice_region_variant&intron_variant:LOW:exon4/19:c.315-4_315-3insT:,MRE11A:NM_005590.3:splice_region_variant&intron_variant:LOW:exon4/18:c.315-4_315-3insT:		rs71036325	0	0	0	0				600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];				RCV000162501.1 [likely benign]; 			0	354	1	[1] old entry - no details available		TAS1R3 (inh=n/a pLI=n/a)
chr11	108183167	108183167	A	G	hom		QUAL=14153;DP=443;AF=1.00;MQM=60	ATM	missense_variant	ATM:NM_000051.3:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1	1	1	0	-1.0580	T	T,T	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				RCV000128947.1,RCV000120149.2 [benign,benign]; 			2669	0				DVL1 (inh=AD pLI=0.16)
chr15	43701947	43701947	A	-	het		QUAL=708;DP=58;AF=0.43;MQM=60	TP53BP1,TUBGCP4,RNU6-28P	splice_region_variant&intron_variant,downstream_gene_variant,intron_variant	TP53BP1:NM_001141980.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5306-8delT:,TP53BP1:NM_001141979.1:splice_region_variant&intron_variant:LOW:exon24/27:c.5300-8delT:,TP53BP1:NM_005657.2:splice_region_variant&intron_variant:LOW:exon24/27:c.5291-8delT:,TUBGCP4:NM_001286414.1:downstream_gene_variant:MODIFIER::c.*2300delA:,TUBGCP4:NM_014444.3:downstream_gene_variant:MODIFIER::c.*2297delA:,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+18528delA:		rs397711844	0.2502	0	0	0										COSM1608394	86	522	1	[1] old entry - no details available		CCNL2 (inh=n/a pLI=0.10)
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense_variant	SLX4:NM_032444.2:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];					CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	1				TMEM88B (inh=n/a pLI=n/a)
